Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA) Targeted CD3-Engaging Bispecific Molecule, for Patients with Relapsed or Refractory Multiple Myeloma: Results from Magnetismm-1
暂无分享，去创建一个
A. Jakubowiak | S. Trudel | M. Tomasson | A. Lesokhin | N. Raje | M. Damore | M. Sebag | M. Chu | M. Solh | C. Basu | C. Costello | N. Bahlis | C. Gasparetto | A. Skoura | B. Dholaria | M. Levy | A. Dalovisio | H. Dube | Hoi Ken Lon | E. Chan